| |
Mission of Screening Technologies Branch
The STB is the organizational component of the Developmental Therapeutics Program responsible for the development and operation of in vitro drug screening
tools and detailed development and investigation of novel therapeutic agents for the treatment of cancer. This is accomplished through research contracts, projects conducted by Operations
and Technical Support Contractor (SAIC) at NCI-Frederick and efforts of staff scientists. Robert H. Shoemaker,
Chief of the STB, is responsible for the scientific management of the branch. To examine various arms of the STB, visit the pages below.
Development of Molecular-Targeted Therapeutics
|
Screening and Drug Discovery
Computational Chemistry and Biology
|
|
